lncRNA FLJ20021 regulates CDK1-mediated PANoptosis in a ZBP1-dependent manner to increase the sensitivity of laryngeal cancer-resistant cells to cisplatin | Discover Oncology
商品説明・詳細
送料・お届け
商品情報
lncRNA FLJ20021 regulates CDK1-mediated PANoptosis in a ZBP1-dependent manner to increase the sensitivity of laryngeal cancer-resistant cells to cisplatin | Discover Oncology,Full article: Therapeutic potential of non-starch polysaccharides on type 2 diabetes: from hypoglycemic mechanism to clinical trials,A ZBP1 isoform blocks ZBP1-mediated cell death - ScienceDirect,ZBP1-Mediated Necroptosis: Mechanisms and Therapeutic Implications,The Transcription Factor IRF9 Promotes Colorectal Cancer via Modulating the IL-6/STAT3 Signaling Axis